771 related articles for article (PubMed ID: 33742613)
1. Posterior Reversible Encephalopathy Syndrome in a Pediatric COVID-19 Patient.
Korkmazer B; Ozogul M; Hikmat E; Kilic H; Aygun F; Arslan S; Kizilkilic O; Kocer N
Pediatr Infect Dis J; 2021 Jun; 40(6):e240-e242. PubMed ID: 33742613
[TBL] [Abstract][Full Text] [Related]
2. Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient.
Princiotta Cariddi L; Tabaee Damavandi P; Carimati F; Banfi P; Clemenzi A; Marelli M; Giorgianni A; Vinacci G; Mauri M; Versino M
J Neurol; 2020 Nov; 267(11):3157-3160. PubMed ID: 32583053
[TBL] [Abstract][Full Text] [Related]
3. Posterior Reversible Encephalopathy Syndrome in Patients with Coronavirus Disease 2019: Two Cases and A Review of The Literature.
Anand P; Lau KHV; Chung DY; Virmani D; Cervantes-Arslanian AM; Mian AZ; Takahashi CE
J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105212. PubMed ID: 33066908
[TBL] [Abstract][Full Text] [Related]
4. Posterior reversible encephalopathy syndrome - A pathology that should not be overlooked in the era of COVID-19.
Ioan P; Ribigan AC; Rusu O; Bratu IF; Badea RS; Antochi F
Am J Emerg Med; 2022 Jun; 56():393.e5-393.e8. PubMed ID: 35346531
[TBL] [Abstract][Full Text] [Related]
5. Posterior reversible encephalopathy syndrome during convalescence from COVID-19.
Michel-Chávez A; García-Grimshaw M; Chávez-Martínez OA; Cantú-Brito C; Romero-Sánchez GT; Flores-Silva FD; Merayo-Chalico FJ; Martínez-Carrillo FM; Barrera-Vargas A; Valdés-Ferrer SI
Int J Neurosci; 2023 Jun; 133(6):672-675. PubMed ID: 34370958
[No Abstract] [Full Text] [Related]
6. COVID-19-Associated PRES-like Encephalopathy with Perivascular Gadolinium Enhancement.
Conte G; Avignone S; Carbonara M; Meneri M; Ortolano F; Cinnante C; Triulzi F
AJNR Am J Neuroradiol; 2020 Dec; 41(12):2206-2208. PubMed ID: 32816769
[TBL] [Abstract][Full Text] [Related]
7. Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19.
Lallana S; Chen A; Requena M; Rubiera M; Sanchez A; Siegler JE; Muchada M
J Clin Neurosci; 2021 Jun; 88():108-112. PubMed ID: 33992168
[TBL] [Abstract][Full Text] [Related]
8. Posterior Reversible Encephalopathy Syndrome.
Gewirtz AN; Gao V; Parauda SC; Robbins MS
Curr Pain Headache Rep; 2021 Feb; 25(3):19. PubMed ID: 33630183
[TBL] [Abstract][Full Text] [Related]
9. Posterior Reversible Encephalopathy Syndrome and brain haemorrhage as COVID-19 complication: a review of the available literature.
Motolese F; Ferrante M; Rossi M; Magliozzi A; Sbarra M; Ursini F; Marano M; Capone F; Travaglino F; Antonelli Incalzi R; Di Lazzaro V; Pilato F
J Neurol; 2021 Dec; 268(12):4407-4414. PubMed ID: 34291313
[TBL] [Abstract][Full Text] [Related]
10. Posterior reversible encephalopathy syndrome (PRES) associated with SARS-CoV-2 infection in a patient under maintenance haemodialysis: a case report.
Shimamoto Y; Sasaki H; Kasuno K; Watanabe Y; Sakashita S; Nishikawa S; Nishimori K; Morita S; Nishikawa Y; Kobayashi M; Fukushima S; Enomoto S; Takahashi N; Hamano T; Sakamaki I; Iwasaki H; Iwano M
BMC Nephrol; 2023 Sep; 24(1):286. PubMed ID: 37773103
[TBL] [Abstract][Full Text] [Related]
11. Posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome in patients with COVID-19 infection: is there a link? A systematic review and case report analysis.
Bonura A; Iaccarino G; Rossi SS; Capone F; Motolese F; Calandrelli R; Di Lazzaro V; Pilato F
J Neurol; 2023 Jun; 270(6):2826-2852. PubMed ID: 37014421
[TBL] [Abstract][Full Text] [Related]
12. Posterior reversible encephalopathy syndrome in critical COVID-19 patients: Report of 2 cases.
Tortajada Soler JJ; Tauler Redondo MP; Garví López M; Lozano Serrano MB; López-Torres López J; Sánchez López ML
Rev Esp Anestesiol Reanim (Engl Ed); 2023 Jan; 70(1):51-55. PubMed ID: 36621570
[TBL] [Abstract][Full Text] [Related]
13. COVID-19-related Posterior Reversible Encephalopathy Syndrome in an Adult ICU Patient in Ireland.
Lal S; Khan E; Diviney D; Thomas J; Hassan T; Counihan I
J Coll Physicians Surg Pak; 2021 Jan; 31(1):S87-S89. PubMed ID: 34530540
[TBL] [Abstract][Full Text] [Related]
14. Encephalopathy with progression to posterior reversible encephalopathy pattern in a patient with COVID-19: clinical, imaging findings and follow-up.
Kerro A
BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33622758
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 may play a direct role in the pathogenesis of posterior reversible encephalopathy syndrome (PRES) associated with COVID-19: A CARE-compliant case report and literature review.
Wang L; Wang Z; Huang R; Li W; Zheng D
Medicine (Baltimore); 2024 Feb; 103(5):e37192. PubMed ID: 38306528
[TBL] [Abstract][Full Text] [Related]
16. Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19.
Kishfy L; Casasola M; Banankhah P; Parvez A; Jan YJ; Shenoy AM; Thomson C; AbdelRazek MA
J Neurol Sci; 2020 Jul; 414():116943. PubMed ID: 32474362
[TBL] [Abstract][Full Text] [Related]
17. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
[TBL] [Abstract][Full Text] [Related]
18. Response to correspondence concerning "Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19".
Lallana S; Siegler JE
J Clin Neurosci; 2021 Oct; 92():189-190. PubMed ID: 34509250
[No Abstract] [Full Text] [Related]
19. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
Harapan BN; Yoo HJ
J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
[TBL] [Abstract][Full Text] [Related]
20. Posterior Reversible Leucoencephalopathy Syndrome: Case Series, Comments, and Diagnostic Dilemma.
Chaudhuri J; Basu S; Roy MK; Chakravarty A
Curr Neurol Neurosci Rep; 2023 Aug; 23(8):433-449. PubMed ID: 37378723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
